Literature DB >> 33016313

Brain angiotensin converting enzyme-2 in central cardiovascular regulation.

Mazher Mohammed1,2, Clara Berdasco1, Eric Lazartigues1,2,3.   

Abstract

The brain renin-angiotensin system (RAS) plays an important role in the regulation of autonomic and neuroendocrine functions, and maintains cardiovascular homeostasis. Ang-II is the major effector molecule of RAS and exerts most of its physiological functions, including blood pressure (BP) regulation, via activation of AT1 receptors. Dysregulation of brain RAS in the central nervous system results in increased Ang-II synthesis that leads to sympathetic outflow and hypertension. Brain angiotensin (Ang) converting enzyme-2 (ACE2) was discovered two decades ago as an RAS component, exhibiting a counter-regulatory role and opposing the adverse cardiovascular effects produced by Ang-II. Studies using synthetic compounds that can sustain the elevation of ACE2 activity or genetically overexpressed ACE2 in specific brain regions found various beneficial effects on cardiovascular function. More recently, ACE2 has been shown to play critical roles in neuro-inflammation, gut dysbiosis and the regulation of stress and anxiety-like behaviors. In the present review, we aim to highlight the anatomical locations and functional implication of brain ACE2 related to its BP regulation via modulation of the sympathetic nervous system and discuss the recent developments and future directions in the ACE2-mediated central cardiovascular regulation.
© 2020 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  HPA axis; autonomic nervous system; cardiovascular physiology; neuro–immune interactions; renin-angiotensin system

Mesh:

Substances:

Year:  2020        PMID: 33016313      PMCID: PMC7640374          DOI: 10.1042/CS20200483

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  125 in total

1.  Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction.

Authors:  Tatiane M Murça; Patrícia L Moraes; Carolina A B Capuruço; Sérgio H S Santos; Marcos B Melo; Robson A S Santos; Vinayak Shenoy; Michael J Katovich; Mohan K Raizada; Anderson J Ferreira
Journal:  Regul Pept       Date:  2012-05-14

2.  Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure.

Authors:  Rohit Ramchandra; Sally G Hood; Anna M D Watson; Andrew M Allen; Clive N May
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

Review 3.  The circumventricular organs and the central actions of angiotensin.

Authors:  J B Simpson
Journal:  Neuroendocrinology       Date:  1981-04       Impact factor: 4.914

4.  Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

Authors:  Minghao Ye; Jan Wysocki; Parveen Naaz; Mohammad Reza Salabat; Michael S LaPointe; Daniel Batlle
Journal:  Hypertension       Date:  2004-04-12       Impact factor: 10.190

5.  Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.

Authors:  Jan Wysocki; Minghao Ye; Eva Rodriguez; Francisco R González-Pacheco; Clara Barrios; Karla Evora; Manfred Schuster; Hans Loibner; K Bridget Brosnihan; Carlos M Ferrario; Josef M Penninger; Daniel Batlle
Journal:  Hypertension       Date:  2009-11-30       Impact factor: 10.190

6.  Angiotensin II excites paraventricular nucleus neurons that innervate the rostral ventrolateral medulla: an in vitro patch-clamp study in brain slices.

Authors:  Matthew J Cato; Glenn M Toney
Journal:  J Neurophysiol       Date:  2004-09-08       Impact factor: 2.714

7.  Impermeability of the blood-cerebrospinal fluid barrier for angiotensin II in rats.

Authors:  P Schelling; J S Hutchinson; U Ganten; G Sponer; D Ganten
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

8.  NaCl injections in brain induce natriuresis and blood pressure responses sensitive to ANG II AT1 receptors.

Authors:  P Rohmeiss; C Beyer; E Nagy; C Tschöpe; S Höhle; M Strauch; T Unger
Journal:  Am J Physiol       Date:  1995-08

Review 9.  Contributions of vascular inflammation in the brainstem for neurogenic hypertension.

Authors:  Hidefumi Waki; Sabine S Gouraud; Masanobu Maeda; Mohan K Raizada; Julian F R Paton
Journal:  Respir Physiol Neurobiol       Date:  2011-05-12       Impact factor: 1.931

Review 10.  Angiotensin-converting enzyme 2 in the brain: properties and future directions.

Authors:  Huijing Xia; Eric Lazartigues
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

View more
  4 in total

1.  Sensory Afferent Renal Nerve Activated Gαi2 Subunit Proteins Mediate the Natriuretic, Sympathoinhibitory and Normotensive Responses to Peripheral Sodium Challenges.

Authors:  Jesse D Moreira; Kayla M Nist; Casey Y Carmichael; Jill T Kuwabara; Richard D Wainford
Journal:  Front Physiol       Date:  2021-11-30       Impact factor: 4.566

Review 2.  A Peek into Pandora's Box: COVID-19 and Neurodegeneration.

Authors:  Abhishek Chandra; Ashu Johri
Journal:  Brain Sci       Date:  2022-01-30

Review 3.  Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation.

Authors:  Anthony J Turner; Natalia N Nalivaeva
Journal:  Peptides       Date:  2022-02-10       Impact factor: 3.750

4.  Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment.

Authors:  Henry Daniell; Smruti K Nair; Yao Shi; Ping Wang; Kathleen T Montone; Pamela A Shaw; Grace H Choi; Danyal Ghani; JoEllen Weaver; Daniel J Rader; Kenneth B Margulies; Ronald G Collman; Krzysztof Laudanski; Katharine J Bar
Journal:  Mol Ther Methods Clin Dev       Date:  2022-07-06       Impact factor: 5.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.